Pediatric Thrombosis

Pediatric thrombosis, while relatively rare, remains a clinically significant issue that is increasingly encountered, particularly among hospitalized children. Despite its importance, there is a recognized gap in clinicians’ knowledge and confidence regarding the evaluation and management of thrombotic events in children. Many pediatricians are unfamiliar with established approaches to thrombophilia evaluation and the interpretation of test results. Additionally, there is limited understanding of the appropriate selection, dosing, and monitoring of commonly used anticoagulants in both inpatient and outpatient pediatric settings. Uncertainty also persists regarding evidence-based recommendations for the duration of anticoagulant therapy in children with venous thromboembolism (VTE). These gaps highlight the need for comprehensive education to improve pediatric providers’ competency in the assessment and management of pediatric thrombosis and to enhance patient safety and outcomes.

Target Audience

Pediatric Residents and Fellows

Learning Objectives

Upon completion of this module, participants will be able to:
  • Explain the pathophysiological mechanisms underlying pediatric venous thromboembolism (VTE) to inform diagnostic reasoning and management decisions.
  • Analyze the contribution of genetic and acquired risk factors to VTE development in pediatric patients to guide targeted investigations.
  • Compare pharmacologic and non-pharmacologic treatment strategies for pediatric VTE, emphasizing mechanisms of action, monitoring, and potential complications.
  • Evaluate how clinical variables such as age, comorbidities, and provoking factors influence the duration and intensity of VTE therapy in children.
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This Enduring activity is designated for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

  • 1.00 ANCC (UK Healthcare CECentral)

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    The maximum number of hours awarded for this Continuing Nursing Education activity is 1.00 nursing contact hour(s).

  • 1.00 Participation
    UK Healthcare CECentral certifies this activity for 1.00 hour(s) of participation.
Course opens: 
10/21/2025
Course expires: 
10/20/2028
Rating: 
0

Dr. Smith is a board certified pediatric hematologist and oncologist at UK Healthcare. He completed his residency training in pediatrics at the University of Tennessee Health Science Center in Memphis, TN, followed by fellowship at Baylor College of Medicine in Houston, TX. He is clinical faculty taking care of a wide variety of hematologic and oncologic conditions, but has interest in bleeding and clotting disorders, heavy menstrual bleeding in adolescents, and iron deficiency anemia

In support of improving patient care, University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
 
CME
This enduring material is designated for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
 
CNE
The maximum number of hours awarded for this Continuing Nursing Education activity is 1 nursing contact hours.
 
Other
UK Healthcare CECentral certifies this activity for 1 hours of participation.
 
Faculty Disclosure
All planners, faculty, and others in control of educational content are required to disclose all their financial relationships with ineligible companies within the prior 24 months.  An ineligible company is defined as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company.
 
None of the planners, faculty, and others in control of educational content for this educational activity have a relevant financial relationship(s) to disclose with ineligible companies.
 
The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include a discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.
 
Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation
 
Acknowledgement
This activity is provided by the University of Kentucky Department of Pediatrics

Available Credit

  • 1.00 AMA PRA Category 1 Credit™

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This Enduring activity is designated for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

  • 1.00 ANCC (UK Healthcare CECentral)

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    The maximum number of hours awarded for this Continuing Nursing Education activity is 1.00 nursing contact hour(s).

  • 1.00 Participation
    UK Healthcare CECentral certifies this activity for 1.00 hour(s) of participation.
Please login or register to take this course.